Legends for Figures
Figure 1. Change in symptom score, quality of life and exhaled nitric
oxide between baseline and follow up visits. (A) Symptom score (TRACK)
at baseline (Visit 1) and follow-up (Visit 2), (B) Change in TRACK
according to level of monitored adherence, (C) Parental and child
quality of life questionnaire (PACQLQ) and (D) exhaled nitric oxide
(FeNO) at baseline and follow up.
Figure 2. Change in symptom score in atopic and non-atopic symptom
between baseline and follow up visit. (A) Symptom score at baseline and
follow-up in atopic children, (B) non-atopic children.
Figure 3. Change in symptom score in atopic children according to level
of adherence. Relationship between adherence and change in symptom score
from baseline (Visit 1) to follow up (Visit 2) in atopic children with
(A) > 60% adherence to inhaled corticosteroids and
(B) <60% adherence to inhaled corticosteroids